INmune Bio and QCi Team Up to Transform Alzheimer’s Treatment with Quantum Computing
Hamid Siddiqui
News
No image for this briefing
INmune Bio and Quantum Computing Inc. have announced a groundbreaking collaboration to leverage quantum computing and AI for developing new applications of XPro, a treatment for Alzheimer's. This partnership marks QCi's entry into the pharmaceutical market and aims to identify predictive biomarkers and potential indications across various diseases. The innovative Dirac-3S quantum machine will align with INmune Bio’s extensive clinical research, enhancing drug development strategies.